ArticleAntioxidants (Basel, Switzerland)2026
An Integrated Screening Study of Polyphenol Recovery from Olive Mill Wastewater Using Cationic Starch-Assisted Clarification and Adsorption Resin Purification.
Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Olive mill wastewater (OMW) is an environmentally problematic effluent but also a rich source of antioxidant phenolic compounds. This study evaluated an integrated recovery approach combining cationic starch clarification and adsorption resin purification for obtaining phenolic-rich fractions from Dalmatian OMW. A pooled OMW sample was characterized for conventional wastewater parameters and total phenolic content (TPC), clarified with four commercial cationic starches, and subsequently processed using Seplite LXA84, Seplite LXA88, Seplite LXA816, and Amberlite XAD4 adsorption resins. PrimePHASE 2545 at 1000 mg active substance L
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.